Refined Balloon Pulmonary Angioplasty for Inoperable Patients with Chronic Thromboembolic Pulmonary Hypertension
Top Cited Papers
- 1 December 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Cardiovascular Interventions
- Vol. 5 (6), 748-755
- https://doi.org/10.1161/circinterventions.112.971077
Abstract
Background— Although balloon pulmonary angioplasty (BPA) for inoperable patients with chronic thromboembolic pulmonary hypertension was first reported over a decade ago, its clinical application has been restricted because of limited efficacy and complications. We have refined the procedure of BPA to maximize its clinical efficacy. Methods and Results— Sixty-eight consecutive patients with inoperable chronic thromboembolic pulmonary hypertension underwent BPA. We evaluated pulmonary artery diameters and determined the appropriate balloon size by using intravascular ultrasound. We performed BPA in a staged fashion over multiple, separate procedures to maximize efficacy and reduce the risk of reperfusion pulmonary injury. A total of 4 (2–8) sessions were performed in each patient, and the number of vessels dilated per session was 3 (1–14). The World Health Organization functional class improved from 3 to 2 (PP<0.01). One patient died because of right heart failure 28 days after BPA. During follow-up for 2.2±1.4 years after the final BPA, another patient died of pneumonia, and the remaining 66 patients are alive. In 57 patients who underwent right heart catheterization at follow-up, improvement of mean pulmonary arterial pressure was maintained (24.0±5.8 mm Hg at 1.0±0.9 years). Forty-one patients (60%) developed reperfusion pulmonary injury after BPA, but mechanical ventilation was required in only 4 patients. Conclusions— Our refined BPA procedure improves clinical status and hemodynamics of inoperable patients with chronic thromboembolic pulmonary hypertension, with a low mortality. A refined BPA procedure could be considered as a therapeutic approach for patients with inoperable chronic thromboembolic pulmonary hypertension.Keywords
This publication has 23 references indexed in Scilit:
- Efficacy of Methylprednisolone in Preventing Lung Injury Following Pulmonary ThromboendarterectomySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Chronic Thromboembolic Pulmonary Hypertension (CTEPH)Circulation, 2011
- Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registryThe Journal of Thoracic and Cardiovascular Surgery, 2011
- Pulmonary Hypertensive Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension Before Pulmonary ThromboendarterectomyCirculation, 2009
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)European Heart Journal, 2009
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary HypertensionCirculation, 2009
- Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a Randomized, Placebo-Controlled TrialJournal of the American College of Cardiology, 2008
- Technical Advances of Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary HypertensionSeminars in Thoracic and Cardiovascular Surgery, 2006
- Postoperative Management of the Patient Undergoing Pulmonary EndarterectomySeminars in Thoracic and Cardiovascular Surgery, 2006
- Catheter-based intravascular ultrasound imaging of chronic thromboembolic pulmonary diseaseThe American Journal of Cardiology, 1991